Endo International M&A Summary
Endo International has acquired 17 companies, including 2 in the last 5 years. A total of 6 acquisitions came from private equity firms. It has also divested 4 assets.
Endo International’s largest acquisition to date was in 2015, when it acquired Par Pharmaceutical Companies for $8.1B. It’s largest disclosed sale occurred in 2015, when it sold American Medical Systems to Boston Scientific for $1.6B. Endo International has acquired in 11 different US states, and 3 countries. The Company’s most targeted sectors include life science (69%) and medical products (32%).
M&A Summary
-
M&A Total Activity20
- M&A Buy Activity16
- M&A Sell Activity4
- Total Sectors Invested 2
- Total Countries Invested 3
- M&A Buy/Sell Connections 11
Unlimited Searches
